In a letter to the Board of Directors of Obagi Medical Products, Inc. (NASDAQ: OMPI) Merz Pharma Group today outlined ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE